Regenerative effects of transplanted mesenchymal stem cells in fracture healing

Stem Cells

Volumn 27, Issue 8, 2009, Pages 1887-1898

  Granero Moltó, Froilán ^a   Weis, Jared A ^a   Miga, Michael I ^c   Landis, Benjamin ^d   Myers, Timothy J ^a   O'Rear, Lynda ^d   Longobardi, Lara ^a   Jansen, E Duco ^c   Mortlock, Douglas P ^e   Spagnoli, Anna ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone morphogenic protein 2; CXCR4; Fracture healing; Mesenchymal stem cells; Stem cell niche

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; CHEMOKINE RECEPTOR CXCR4;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALLUS; CELL MIGRATION; CONTROLLED STUDY; FRACTURE HEALING; INFLAMMATION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; TISSUE REGENERATION; TISSUE REPAIR;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; BONY CALLUS; FEMALE; FRACTURE HEALING; HUMANS; LUMINESCENT PROTEINS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; RECEPTORS, CXCR4; TIBIAL FRACTURES;

BACTERIA (MICROORGANISMS); MUS;

EID: 69249162221     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.103     Document Type: Article

References (55)

1. Keating JF, Blachut PA, O'Brien PJ et al. Reamed nailing of Gustilo grade-IIIB tibial fractures. J Bone Joint Surg 2000;82:1113-1116.
2. Einhorn TA. Enhancement of fracture-healing. J Bone Joint Surg Am 1995;77:940-956.
3. Marsh D. Concepts of fracture union, delayed union, and nonunion. Clin Orthop 1998:S22-S30.
4. Praemer A, Furner S, Rice DP. Musculoskeletal Conditions in the United States. 2nd ed. Rosemont HL, ed. Park Ridge, IL: The American Academy of Orthopaedic Surgeons; 1999, p 83-87.
5. Morshed S, Corrales L, Genant H et al. Outcome assessment in clinical trials of fracture-healing. J Bone Joint Surg Am 2008;90(suppl 1):62-67.
6. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998:S7-S21.
7. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
8. Marcacci M, Kon E, Moukhachev V et al. Stem cells associated with macroporous bioceramics for long bone repair: 6- to 7-year outcome of a pilot clinical study. Tissue Eng 2007;13:947-955.
9. Quarto R, Mastrogiacomo M, Cancedda R et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-386.
10. Hernigou P, Mathieu G, Poignard A et al. Percutaneous autologous bone-marrow grafting for nonunions. Surgical technique. J Bone Joint Surg Am 2006;88(suppl 1; pt 2):322-327.
11. Hernigou P, Poignard A, Beaujean F et al. Percutaneous autologous bone-marrow grafting for nonunions. Influence Of The Number And Concentration of Progenitor Cells. J Bone Joint Surg Am 2005;87:1430-1437.
12. Hernigou P, Poignard A, Manicom O et al. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br 2005;87:896-902.
13. Tseng SS, Lee MA, Reddi AH. Nonunions and the potential of stem cells in fracture-healing. J Bone Joint Surg Am 2008;90(suppl 1):92-98.
14. Chapel A, Bertho JM, Bensidhoum M et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003;5:1028-1038.
15. Gao J, Dennis JE, Muzic RF et al. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001;169:12-20.
16. Barbash IM, Chouraqui P, Baron J et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003;108:863-868.
17. Zou YR, Kottmann AH, Kuroda M et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-599.
18. Wynn RF, Hart CA, Corradi-Perini C et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004;104:2643-2645.
19. Von Lüttichau I, Notohamiprodjo M, Wechselberger A et al. Human adult CD34- progenitor cells functionally express the chemokine receptors CCR1, CCR4, CCR7, CXCR5, and CCR10 but not CXCR4. Stem Cells Dev 2005;14:329-336.
20. Granero-Molto F, Weis JA, Longobardi L et al. Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair. Expert Opin Biol Ther 2008;8:255-268.
21. Le Blanc K, Gotherstrom C, Ringden O et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005;79:1607-1614.
22. da Silva Meirelles L, Caplan AI, Nardi NB. In search of the in vivo identity of mesenchymal stem cells. Stem Cells 2008;26:2287-2299.
23. Ortiz LA, Gambelli F, McBride C et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U S A 2003;100:8407-8411.
24. Zappia E, Casazza S, Pedemonte E et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 2005;106:1755-1761.
25. Parekkadan B, van Poll D, Suganuma K et al. Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. Plos One 2007;2:e941.
26. Bartholomew A, Sturgeon C, Siatskas M et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002;30:42-48.
27. Le Blanc K, Frassoni F, Ball L et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 2008;371:1579-1586.
28. Bruder SP, Jaiswal N, Ricalton NS et al. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop 1998:S247-S256.
29. Petite H, Viateau V, Bensaid W et al. Tissue-engineered bone regeneration. Nat Biotechnol 2000;18:959-963.
30. Bonnarens F, Einhorn TA. Production of a standard closed fracture in laboratory animal bone. J Orthop Res 1984;2:97-101.
31. Spagnoli A, Longobardi L, O'Rear L. Cartilage disorders: potential therapeutic use of mesenchymal stem cells. Endocr Dev 2005;9:17-30.
32. Chandler RL, Chandler KJ, McFarland KA et al. Bmp2 transcription in osteoblast progenitors is regulated by a distant 30 enhancer located 156.3 kilobases from the promoter. Mol Cell Biol 2007;27:2934-2951.
33. Fowler M, Virostko J, Chen Z et al. Assessment of pancreatic islet mass after islet transplantation using in vivo bioluminescence imaging. Transplantation 2005;79:768-776.
34. Deal KK, Cantrell VA, Chandler RL et al. Distant regulatory elements in a Sox10-beta GEO BAC transgene are required for expression of Sox10 in the enteric nervous system and other neural crest-derived tissues. Dev Dyn 2006;235:1413-1432.
35. Spagnoli A, O'Rear L, Chandler RL et al. TGF-beta signaling is essential for joint morphogenesis. J Cell Biol 2007;177:1105-1117.
36. Reynolds DG, Hock C, Shaikh S et al. Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. J Biomech 2007;40:3178-3186.
37. Longobardi L, O'Rear L, Aakula S et al. Effect of IGF-I in the chondrogenesis of bone marrow mesenchymal stem cells in the presence or absence of TGF-beta signaling. J Bone Miner Res 2006;21:626-636.
38. Nolan GP, Fiering S, Nicolas JF et al. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci U S A 1988;85:2603-2607.
39. Devine MJ, Mierisch CM, Jang E et al. Transplanted bone marrow cells localize to fracture callus in a mouse model. J Orthop Res 2002;20:1232-1239.
40. Honczarenko M, Le Y, Swierkowski M et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 2006;24:1030-1041.
41. Chamberlain G, Wright K, Rot A et al. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. Plos One 2008;3:e2934.
42. Fox JM, Chamberlain G, Ashton BA et al. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 2007;137:491-502.
43. Tsuji K, Bandyopadhyay A, Harfe BD et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 2006;38:1424-1429.
44. Kumagai K, Vasanji A, Drazba JA et al. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 2008;26:165-175.
45. Peled A, Petit I, Kollet O et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999;283:845-848.
46. Rombouts WJ, Ploemacher RE. Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture. Leukemia 2003;17:160-170.
47. Cheng Z, Ou L, Zhou X et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008;16:571-579.
48. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 1994;56:283-294.
49. Szulc P, Delmas PD. Bone loss in elderly men: increased endosteal bone loss and stable periosteal apposition. The Prospective Minos Study. Osteoporos Int 2007;18:495-503.
50. Markel MD, Wikenheiser MA, Chao EY. A study of fracture callus material properties: relationship to the torsional strength of bone. J Orthop Res 1990;8:843-850.
51. Rutten S, Nolte PA, Korstjens CM et al. Low-intensity pulsed ultrasound increases bone volume, osteoid thickness and mineral apposition rate in the area of fracture healing in patients with a delayed union of the osteotomized fibula. Bone 2008;43:348-354.
52. Mitsiadis TA, Barrandon O, Rochat A et al. Stem cell niches in mammals. Exp Cell Res 2007;313:3377-3385.
53. Wilson A, Trumpp A. Bone-marrow haematopoietic-stem-cell niches. Nat Rev 2006;6:93-106.
54. Glennie S, Soeiro I, Dyson PJ et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005;105:2821-2827.
55. Jung Y, Song J, Shiozawa Y et al. Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells 2008;26:2042-2051.